Literature DB >> 31176566

Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.

Hongmao Sun1, Pranav Shah2, Kimloan Nguyen2, Kyeong Ri Yu2, Ed Kerns2, Md Kabir2, Yuhong Wang2, Xin Xu3.   

Abstract

Aqueous solubility is one of the most important properties in drug discovery, as it has profound impact on various drug properties, including biological activity, pharmacokinetics (PK), toxicity, and in vivo efficacy. Both kinetic and thermodynamic solubilities are determined during different stages of drug discovery and development. Since kinetic solubility is more relevant in preclinical drug discovery research, especially during the structure optimization process, we have developed predictive models for kinetic solubility with in-house data generated from 11,780 compounds collected from over 200 NCATS intramural research projects. This represents one of the largest kinetic solubility datasets of high quality and integrity. Based on the customized atom type descriptors, the support vector classification (SVC) models were trained on 80% of the whole dataset, and exhibited high predictive performance for estimating the solubility of the remaining 20% compounds within the test set. The values of the area under the receiver operating characteristic curve (AUC-ROC) for the compounds in the test sets reached 0.93 and 0.91, when the threshold for insoluble compounds was set to 10 and 50 μg/mL respectively. The predictive models of aqueous solubility can be used to identify insoluble compounds in drug discovery pipeline, provide design ideas for improving solubility by analyzing the atom types associated with poor solubility and prioritize compound libraries to be purchased or synthesized.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Atom typing descriptors; In silico ADME model; Kinetic solubility; Prediction; Support vector classification (SVC)

Mesh:

Substances:

Year:  2019        PMID: 31176566      PMCID: PMC8274818          DOI: 10.1016/j.bmc.2019.05.037

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  A universal molecular descriptor system for prediction of logP, logS, logBB, and absorption.

Authors:  Hongmao Sun
Journal:  J Chem Inf Comput Sci       Date:  2004 Mar-Apr

Review 2.  Toward in silico structure-based ADMET prediction in drug discovery.

Authors:  Gautier Moroy; Virginie Y Martiny; Philippe Vayer; Bruno O Villoutreix; Maria A Miteva
Journal:  Drug Discov Today       Date:  2011-10-29       Impact factor: 7.851

3.  Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery.

Authors:  Shobha N Bhattachar; James A Wesley; Christopher Seadeek
Journal:  J Pharm Biomed Anal       Date:  2005-12-20       Impact factor: 3.935

Review 4.  In vitro solubility assays in drug discovery.

Authors:  Edward H Kerns; Li Di; Guy T Carter
Journal:  Curr Drug Metab       Date:  2008-11       Impact factor: 3.731

Review 5.  Cyclin dependent kinase (CDK) inhibitors as anticancer drugs.

Authors:  Concepción Sánchez-Martínez; Lawrence M Gelbert; María José Lallena; Alfonso de Dios
Journal:  Bioorg Med Chem Lett       Date:  2015-06-06       Impact factor: 2.823

6.  Solubility-excipient classification gradient maps.

Authors:  Alex Avdeef; Stefanie Bendels; Oksana Tsinman; Konstantin Tsinman; Manfred Kansy
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

7.  Prediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug-like Molecules.

Authors:  Hongmao Sun; Henrike Veith; Menghang Xia; Christopher P Austin; Raymond R Tice; Ruili Huang
Journal:  Mol Inform       Date:  2012-10-11       Impact factor: 3.353

8.  Escape from flatland: increasing saturation as an approach to improving clinical success.

Authors:  Frank Lovering; Jack Bikker; Christine Humblet
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

9.  Binary classification of aqueous solubility using support vector machines with reduction and recombination feature selection.

Authors:  Tiejun Cheng; Qingliang Li; Yanli Wang; Stephen H Bryant
Journal:  J Chem Inf Model       Date:  2011-01-07       Impact factor: 4.956

10.  Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?

Authors:  Serge Christmann-Franck; Gerard J P van Westen; George Papadatos; Fanny Beltran Escudie; Alexander Roberts; John P Overington; Daniel Domine
Journal:  J Chem Inf Model       Date:  2016-08-11       Impact factor: 4.956

View more
  9 in total

1.  Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors.

Authors:  Li Liu; Manshu Tang; Rajan Pragani; Frank G Whitby; Ya-Qin Zhang; Bijina Balakrishnan; Yuhong Fang; Surendra Karavadhi; Dingyin Tao; Christopher A LeClair; Matthew D Hall; Juan J Marugan; Matthew Boxer; Min Shen; Christopher P Hill; Kent Lai; Samarjit Patnaik
Journal:  J Med Chem       Date:  2021-09-07       Impact factor: 7.446

Review 2.  Retro Drug Design: From Target Properties to Molecular Structures.

Authors:  Yuhong Wang; Sam Michael; Shyh-Ming Yang; Ruili Huang; Kennie Cruz-Gutierrez; Yaqing Zhang; Jinghua Zhao; Menghang Xia; Paul Shinn; Hongmao Sun
Journal:  J Chem Inf Model       Date:  2022-06-02       Impact factor: 6.162

3.  Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.

Authors:  Theresa D Manz; Sindhu Carmen Sivakumaren; Fleur M Ferguson; Tinghu Zhang; Adam Yasgar; Hyuk-Soo Seo; Scott B Ficarro; Joseph D Card; Hyeseok Shim; Chandrasekhar V Miduturu; Anton Simeonov; Min Shen; Jarrod A Marto; Sirano Dhe-Paganon; Matthew D Hall; Lewis C Cantley; Nathanael S Gray
Journal:  J Med Chem       Date:  2020-04-27       Impact factor: 7.446

4.  Small Molecule Inhibitors of Activation-Induced Deaminase Decrease Class Switch Recombination in B Cells.

Authors:  Juan Alvarez-Gonzalez; Adam Yasgar; Robert W Maul; Amanda E Rieffer; Daniel J Crawford; Daniel J Salamango; Dorjbal Dorjsuren; Alexey V Zakharov; Daniel J Jansen; Ganesha Rai; Juan Marugan; Anton Simeonov; Reuben S Harris; Rahul M Kohli; Patricia J Gearhart
Journal:  ACS Pharmacol Transl Sci       Date:  2021-05-07

5.  Discovery and Optimization of 2H-1λ2-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer.

Authors:  Jason M Rohde; Surendra Karavadhi; Rajan Pragani; Li Liu; Yuhong Fang; Weihe Zhang; Andrew McIver; Hongchao Zheng; Qingyang Liu; Mindy I Davis; Daniel J Urban; Tobie D Lee; Dorian M Cheff; Melinda Hollingshead; Mark J Henderson; Natalia J Martinez; Kyle R Brimacombe; Adam Yasgar; Wei Zhao; Carleen Klumpp-Thomas; Sam Michael; Joseph Covey; William J Moore; Gordon M Stott; Zhuyin Li; Anton Simeonov; Ajit Jadhav; Stephen Frye; Matthew D Hall; Min Shen; Xiaodong Wang; Samarjit Patnaik; Matthew B Boxer
Journal:  J Med Chem       Date:  2021-04-06       Impact factor: 7.446

6.  Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.

Authors:  Floriane Montanari; Lara Kuhnke; Antonius Ter Laak; Djork-Arné Clevert
Journal:  Molecules       Date:  2019-12-21       Impact factor: 4.411

7.  Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.

Authors:  Dorjbal Dorjsuren; Richard T Eastman; Anton Simeonov; David A Fidock; Kathryn J Wicht; Daniel Jansen; Daniel C Talley; Benjamin A Sigmon; Alexey V Zakharov; Norma Roncal; Andrew T Girvin; Yevgeniya Antonova-Koch; Paul M Will; Pranav Shah; Hongmao Sun; Carleen Klumpp-Thomas; Sachel Mok; Tomas Yeo; Stephan Meister; Juan Jose Marugan; Leila S Ross; Xin Xu; David J Maloney; Ajit Jadhav; Bryan T Mott; Richard J Sciotti; Elizabeth A Winzeler; Norman C Waters; Robert F Campbell; Wenwei Huang
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

8.  Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment.

Authors:  Amy Q Wang; Natalie R Hagen; Elias C Padilha; Mengbi Yang; Pranav Shah; Catherine Z Chen; Wenwei Huang; Pramod Terse; Philip Sanderson; Wei Zheng; Xin Xu
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

9.  Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants.

Authors:  Sankalp Jain; Daniel C Talley; Bolormaa Baljinnyam; Jun Choe; Quinlin Hanson; Wei Zhu; Miao Xu; Catherine Z Chen; Wei Zheng; Xin Hu; Min Shen; Ganesha Rai; Matthew D Hall; Anton Simeonov; Alexey V Zakharov
Journal:  ACS Pharmacol Transl Sci       Date:  2021-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.